Union Textiles Minister Giriraj Singh on Monday, 25 May 2026, shared a report highlighting that India's medical tourism revenue recorded growth in FY26 despite disruptions caused by the West Asia conflict and the Bangladesh crisis, posting the development via the NaMo App on his official X account.

Context

The post, shared in Hindi, translates as: 'Pashchim Asia aur Bangladesh sankat ke bawajood FY26 mein badha Bharat ka medical tourism revenue' ['Despite the West Asia and Bangladesh crisis, India's medical tourism revenue grew in FY26']. The minister's amplification of the data signals the ruling establishment's interest in projecting India's services sector resilience even as two of its key source-market corridors faced significant stress.

West Asia has historically been a major origin region for patients travelling to India for affordable, high-quality medical care. Bangladesh, which shares a long land border with India, has also been a consistent and large source of medical tourists, particularly for patients seeking treatment at hospitals in Kolkata and other eastern Indian cities. Political instability in Dhaka and conflict-driven travel disruptions across West Asia had raised concerns about a potential dip in inflows during the fiscal year.

Policy Backdrop

India's push to position itself as a medical value travel destination dates to the early 2000s, with the Ministry of Tourism and the Ministry of Health jointly promoting the sector. Dedicated Medical Visa categories were introduced between 2005 and 2010, and e-visa facilities were expanded between 2014 and 2016 to cover medical treatment, broadening access for patients from neighbouring countries and the Gulf region.

Medical tourism has been treated by successive governments as a strategic services-export sector alongside IT and wellness tourism, with hospital accreditation frameworks and visa liberalisation used as key policy levers. The sector contributes to foreign exchange earnings and supports a wide ecosystem of hospitals, diagnostics, hospitality, and allied services across the country.

Stakeholders and Impact

Healthcare providers — particularly large private hospital chains with internationally accredited facilities — stand to benefit most directly from sustained inbound patient flows. The tourism and hospitality industry, including medical facilitation agencies and specialised accommodation, also depends significantly on this segment.

For international patients, especially those from lower-income brackets in South Asia and Africa, India's cost advantage relative to Western healthcare systems remains a primary draw. The FY26 growth figure, if confirmed by official statistics, would reinforce India's positioning as a preferred destination even when geopolitical headwinds affect traditional travel patterns.

What's Next

The Ministry of Tourism and the Ministry of Health are expected to release comprehensive annual medical tourism statistics in the second half of 2026, which will provide verified figures on patient arrivals and revenue. Analysts and industry stakeholders will watch for any fresh budgetary allocations or regulatory updates related to hospital accreditation and medical visa processing in the coming months.

The broader pattern suggests that India's health services trade has consistently demonstrated counter-cyclical growth during episodes of regional geopolitical stress — a trend that, if sustained in FY26, would strengthen the case for deeper policy investment in the sector.